Latest Director Remuneration News

S2 Resources secured new tenements, completed heritage and aeromagnetic surveys, and obtained drilling approvals across WA, NSW, and Victoria, maintaining a robust cash position of A$18.57 million.

I Synergy Group has appointed Anson Heng as Executive Chairman and Managing Director to spearhead its strategic cooperation with Macau Direch, formalised through a non-binding MoU targeting blockchain, AI, and digital asset initiatives.

Entropy Neurodynamics has reported breakthrough Phase 2 clinical results for its intravenous psilocin therapy in treatment-resistant Binge Eating Disorder, alongside strong Phase 2a data in Irritable Bowel Syndrome and a new US patent filing.

Buru Energy pushes forward with its Rafael Gas Project development, securing A$5.3 million in funding and progressing environmental approvals while navigating executive leadership changes.

Nexalis Therapeutics has issued share rights to directors in lieu of fees, with vesting contingent on successful Phase 2 clinical trial completion, aiming to conserve cash for ongoing drug development.

Group 6 Metals set a new quarterly record processing 77,953 tonnes at its Dolphin Tungsten Mine, producing 21,297 MTUs of tungsten concentrate despite lower feed grades. The company strengthened its cash position to $49.5 million and commenced underground mining, aiming to improve grades and recovery in coming quarters.

Marquee Resources (ASX:MQR) is raising just over $1 million through a non-renounceable rights issue priced at half a cent per share, accompanied by free attaching options. The capital raise aims to support ongoing exploration and the recent acquisition of the Tungsten Mountain Project in Nevada.

Terra Metals appoints Debra Bakker as Chair alongside Jeff Quartermaine and Jennifer Purdie to steer the company’s shift from exploration to development at its promising Dante Project in Western Australia.

Critical Minerals Group (ASX: CMG) has secured $1.5 million through a discounted two-tranche placement to accelerate its vanadium electrolyte strategy, including feasibility studies and offtake negotiations.

Bounty Oil & Gas NL has issued a prospectus offering over 632 million new options to eligible investors as part of a broader recapitalisation, potentially raising $6.3 million if exercised.

Findi Limited has transitioned Stephen Benton to Non-Executive Chairman while Nicholas Smedley refocuses on the Indian business and TSI IPO plans. A strategic review aims to sharpen capital allocation and progress the Payments Bank licence.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.